Content type

Guardant Health Companion Diagnostic Becomes The First Blood Test To Gain Approval In Singapore For Advanced Solid Cancers

Medical Devices / Singapore / Wed 31 May, 2023

Key View

  • The regulatory approval of Guardant360 CDx in Singapore will be crucial in improving cancer diagnosis and effective treatment for the disease in the country.
  • We expect to see more approvals of Guardant360 CDx in key markets such as the US, Asia-Pacific and Europe, supported by Guardant Health’s partnerships with targeted oncology
Read More

Singapore's Health Expenditure Set To Decrease In 2023, But Support For The Country's Ageing Population Remains Strong

Healthcare / Singapore / Fri 17 Feb, 2023

Key View

  • Singapore’s health expenditure is set to decrease in 2023 but will remain higher than pre-pandemic levels.
  • Singapore’s government will provide more financial support for the elderly and individuals struggling to pay their medical bills, which will ensure that the country’s healthcare system remains widely accessible.
  • The government
Read More

Singapore Consumer Sector Will Benefit From Easing Of Travel Restrictions In Mainland China Despite Downside Risks

Consumer & Retail / Singapore / Wed 04 Jan, 2023

Key View

  • The Singapore tourism industry has yet to fully recover post-Covid. However, the market will benefit as Mainland China relaxes travel restrictions for its citizens.
  • The projected return of Mainland Chinese travellers will also boost the luxury retail sector in Singapore, as the city was a key global centre for luxury shopping before
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.